<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58-molecules-24-01552">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Braun</surname>
    <given-names>D.L.</given-names>
   </name>
   <name>
    <surname>Rauch</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Aouri</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Durisch</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Eberhard</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Anagnostopoulos</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ledergerber</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>MÃ¼llhaupt</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Metzner</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Decosterd</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients</article-title>
  <source>PLoS ONE</source>
  <year>2015</year>
  <volume>10</volume>
  <elocation-id>e0133028</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0133028</pub-id>
  <pub-id pub-id-type="pmid">26176696</pub-id>
 </element-citation>
</ref>
